Delaying rejection in discordant heart xenografts in the rat: efficacy of cyclosporin, prostaglandin I2 and exchange transfusion.
If effective modes of prevention of hyperacute rejection were available, the problem of the absence of enough suitable donors could be solved by the use of organ xenografts. Organ xenograft rejection is principally mediated by preformed antibodies which are responsible for the hyperacute pattern of rejection. We decided therefore to study various methods of prevention of rejection in the guinea pig to Lewis rat combination (donor-recipient discordant species) in which hyperacute rejection is particularly intense. Three series of experiments were performed. In the first series immunosuppression of the recipient was induced using an oral solution of cyclosporin A. In the second series antiplatelet-aggregation therapy was administered to the recipient, using intravenous prostacyclin (PGI2). In the third series antibody depletion of the recipient was attempted using exchange transfusion with or without prostacyclin perfusion. The most significant (p less than 0.01) prolongation of graft survival time was observed when combining exchange transfusion (8 ml) and PGI2 infusion (620 ng/kg/min). This observation suggests that, if antibody depletion in the recipient is the primary goal, measures aiming at reducing the consequences of the antigen-antibody reaction are also necessary to improve the results of organ xenografting.
Meriggi
F
F
Clinica Chirugica, Università di Pavia, IRCCS Ospedale San Matteo, Pavia, Italy.
Gigou
M
M
Capron
M
M
Houssin
D
D
Forni
E
E
D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use*; D011464:Epoprostenol / Q000627:therapeutic use*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006168:Guinea Pigs; D016027:Heart Transplantation; D008297:Male; D009206:Myocardium / Q000473:pathology; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous
D003524:Cyclosporins; D011464:Epoprostenol